# Vitamin D3 (Vit D3) Supplementation and T Cell Immunomodulation in Patients With Newly Diagnosed Operative Invasive Ductal Breast Carcinoma

> **NCT01816555** · PHASE1 · TERMINATED · sponsor: **Medical University of South Carolina** · enrollment: 1 (actual)

## Conditions studied

- Newly Diagnosed Operative Invasive Ductal Breast Carcinoma Stage I-II

## Interventions

- **DIETARY_SUPPLEMENT:** Vitamin D

## Key facts

- **NCT ID:** NCT01816555
- **Lead sponsor:** Medical University of South Carolina
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-01
- **Primary completion:** 2014-11
- **Final completion:** 2014-11
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Study closed due to low accrual.
- **Last updated:** 2015-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01816555

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01816555, "Vitamin D3 (Vit D3) Supplementation and T Cell Immunomodulation in Patients With Newly Diagnosed Operative Invasive Ductal Breast Carcinoma". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01816555. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*